CoChat

Guidance on the scientific requirements for health claims related to muscle function and physical performance: (Revision 1)

Open access
EFSA Panel on Nutrition, Novel Foods and Food Allergens (EFSA NDA Panel), Turck, Dominique, Castenmiller, Jacqueline, De Henauw, Stefaan, Hirsch‐Ernst, Karen Ildico, Kearney, John, Knutsen, Helle Katrine, Maciuk, Alexandre, Mangelsdorf, Inge, McArdle, Harry J, Naska, Androniki, Pelaez, Carmen, Pentieva, Kristina, Thies, Frank, Tsabouri, Sophia, Vinceti, Marco, Bresson, Jean‐Louis, Burlingame, Barbara, Dean, Tara, Fairweather‐Tait, Susan, Heinonen, Marina, Neuhäuser‐Berthold, Monika, Nowicka, Grażyna, Sanz, Yolanda, Sjödin, Anders, Stern, Martin, Tomé, Daniel, Van Loveren, Henk, Willatts, Peter, Martin, Ambroise, Strain, John Joseph, Heng, Leng, Valtueña Martínez, Silvia, Siani, Alfonso · 2018 · EFSA Journal
Cited by 19

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

EFSA has asked the Panel on Nutrition, Novel Foods and Food Allergens (NDA) to update the guidance on the scientific requirements for health claims related to physical performance published in 2012. The update takes into account the experience gained by the NDA Panel with the evaluation of additional health claim applications, changes introduced to the general scientific guidance for stakeholders for health claims applications and information collected from a grant launched in 2014 which aimed at gathering information in relation to claimed effects, outcome variables and methods of measurement in the context of the scientific substantiation of health claims. The guidance is intended to assist applicants in preparing applications for the authorisation of health claims related to muscle function and physical performance. The draft guidance was subject to public consultation from 16 July to 2 September 2018. This document supersedes the guidance on the scientific requirements for health claims related to physical performance published in 2012. It is intended that the guidance will be further updated as appropriate in the light of experience gained from the evaluation of health claims.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2903/j.efsa.2018.5434

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 42

  1. Caspersen, 1985, Physical activity, exercise, and physical fitness: definitions and distinctions for health‐related research, Public Health Reports, 100, 126
  2. Chamari, 2015, ‘Aerobic’ and ‘Anaerobic’ terms used in exercise physiology: a critical terminology reflection, Sports Medicine ‐ Open, 1, 9, 10.1186/s40798-015-0012-1 · DOI · Paper page
  3. Chodzko‐Zajko, 2009, American College of Sports Medicine position stand. Exercise and physical activity for older adults, Medicine and Science in Sports and Exercise, 41, 1510, 10.1249/MSS.0b013e3181a0c95c · DOI · Paper page
  4. EFSA NDA Panel, 2009, Scientific Opinion on the substantiation of health claims related to calcium and growth, development and maintenance of the normal structure and function of bones and teeth (ID 224, 230, 231, 354, 3099), muscle function and neurotransmission (ID 226, 227, 230, 235), blood coagulation (ID 230, 236), energy‐yielding metabolism (ID 234), normal function of digestive enzymes (ID 355), and maintenance of a normal blood pressure (ID 225, 385, 1419) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 7, 1210
  5. EFSA NDA Panel, 2009, Scientific Opinion on the substantiation of health claims related to taurine and protection of DNA, proteins and lipids from oxidative damage (ID 612, 1658, 1959), energy‐yielding metabolism (ID 614), and delay in the onset of fatigue and enhancement of physical performance (ID 1660) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 7, 1260
  6. EFSA NDA Panel, 2009, Scientific Opinion on the substantiation of health claims related to magnesium and electrolyte balance (ID 238), energy‐yielding metabolism (ID 240, 247, 248), neurotransmission and muscle contraction including heart muscle (ID 241, 242), cell division (ID 365), maintenance of bone (ID 239), maintenance of teeth (ID 239), blood coagulation (ID 357) and protein synthesis (ID 364) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 7, 1216
  7. EFSA NDA Panel, 2010, Scientific Opinion on the substantiation of health claims related to protein and increase in satiety leading to a reduction in energy intake (ID 414, 616, 730), contribution to the maintenance or achievement of a normal body weight (ID 414, 616, 730), maintenance of normal bone (ID 416) and growth or maintenance of muscle mass (ID 415, 417, 593, 594, 595, 715) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 8, 1811, 10.2903/j.efsa.2010.1811 · DOI
  8. EFSA NDA Panel, 2010, Scientific Opinion on the substantiation of health claims related to superoxide dismutase (SOD) and protection of DNA, proteins and lipids from oxidative damage (ID 1785, 1839, 1970, 2304, 2305, 3159, 3160), protection of the skin from photo‐oxidative (UV‐induced) damage (ID 2305, 3161), reduction of muscle fatigue during exercise (ID 1840), and “effects on immune system” (ID 2304, 3160) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 8, 1753
  9. EFSA NDA Panel, 2010, Scientific Opinion on the substantiation of health claims related to whey protein and increase in satiety leading to a reduction in energy intake (ID 425), contribution to the maintenance or achievement of a normal body weight (ID 1683), growth and maintenance of muscle mass (ID 418, 419, 423, 426, 427, 429, 4307), increase in lean body mass during energy restriction and resistance training (ID 421), reduction of body fat mass during energy restriction and resistance training (ID 420, 421), increase in muscle strength (ID 422, 429), increase in endurance capacity during the subsequent exercise bout after strenuous exercise (ID 428), skeletal muscle tissue repair (ID 428) and faster recovery from muscle fatigue after exercise (ID 423, 428, 431), pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 8, 1818
  10. EFSA NDA Panel, 2010, Scientific Opinion on the substantiation of health claims related to beta‐alanine and increase in physical performance during short‐term high‐intensity exercise (ID 436, 1453, 1454, 1459), increase in time to exhaustion (ID 437, 438, 439, 683, 1452, 1455, 1456, 1459) and increase in muscle carnosine stores (ID 1457, 1458) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 8, 1729
  11. EFSA NDA Panel, 2010, Scientific Opinion on the substantiation of health claims related to soy phosphatidyl choline and maintenance of normal blood cholesterol concentrations (ID 709, 1308, 1630, 1961, 3138, 3187, 4687), contribution to normal fat metabolism (ID 1597), increase in the intestinal absorption of glutamine (ID 4251), faster recovery from muscle fatigue after exercise (ID 4249), improvement of neuromuscular function (ID 4250), contribution to normal cognitive function (ID 710, 1596, 1631, 1983) and maintenance of normal neurological function (ID 1596) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 8, 1741
  12. EFSA NDA Panel, 2010, Scientific Opinion on the substantiation of health claims related to coenzyme Q10 and contribution to normal energy‐yielding metabolism (ID 1508, 1512, 1720, 1912, 4668), maintenance of normal blood pressure (ID 1509, 1721, 1911), protection of DNA, proteins and lipids from oxidative damage (ID 1510), contribution to normal cognitive function (ID 1511), maintenance of normal blood cholesterol concentrations (ID 1721) and increase in endurance capacity and/or endurance performance (ID 1913) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 8, 1793, 10.2903/j.efsa.2010.1793 · DOI
  13. EFSA NDA Panel, 2010, Scientific Opinion on the substantiation of health claims related to branched‐chain amino acids (BCAA) and growth or maintenance of muscle mass (ID 442, 444, 445, 447, 448, 451, 1478), attenuation of the decline in muscle power following exercise at high altitude (ID 443), faster recovery from muscle fatigue after exercise (ID 447, 448, 684,1478), improvement of cognitive function after exercise (ID 446), reduction in perceived exertion during exercise (ID 450) and “healthy immune system” (ID 449) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 8, 1790, 10.2903/j.efsa.2010.1790 · DOI
  14. EFSA NDA Panel, 2010, Scientific Opinion on the substantiation of health claims related to potassium and maintenance of normal muscular and neurological function (ID 320, 386) and maintenance of normal blood pressure (ID 321) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 8, 1469
  15. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to L‐carnitine and faster recovery from muscle fatigue after exercise (ID 738, 1492, 1493), skeletal muscle tissue repair (ID 738, 1492, 1493), increase in endurance capacity (ID 4305, 4684), maintenance of normal blood LDL‐cholesterol concentrations (ID 1494, 4684), contribution to normal spermatogenesis (ID 1822), “energy metabolism” (ID 1821), and increasing L‐carnitine concentrations and/or decreasing free fatty acids in blood during pregnancy (ID 1495) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2212
  16. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to L‐carnosine and increase in muscle power (ID 1824), increase in endurance capacity (ID 1824), “skin” (ID 1825) and maintenance of normal cardiac function (ID 1826) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2038, 10.2903/j.efsa.2011.2038 · doi:10.2903/j.efsa.2011.2038
  17. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to L‐glutamine and growth or maintenance of muscle mass (ID 719, 722, 3185), faster restoration of muscle glycogen stores after strenuous exercise (ID 434, 699, 701, 723, 1569), skeletal muscle tissue repair (ID 721), maintenance of normal neurological function (ID 662, 700), increased attention (ID 700, 1570), improvement of working memory (ID 700, 1570), maintenance of defence against pathogenic gastro‐intestinal microorganisms (ID 452), gut protein synthesis (ID 701), decreasing gut permeability (ID 701), and stimulating immunological responses (ID 1568)pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2225
  18. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to ribose and faster recovery from muscle fatigue after exercise (ID 4226) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2257, 10.2903/j.efsa.2011.2257 · doi:10.2903/j.efsa.2011.2257
  19. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to taurine and “immune system protection” (ID 611), “metabolism processes” (ID 613), contribution to normal cognitive function (ID 1659), maintenance of normal cardiac function (ID 1661), maintenance of normal muscle function (ID 1949) and delay in the onset of physical fatigue during exercise (ID 1958) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2035, 10.2903/j.efsa.2011.2035 · DOI
  20. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to sodium phosphate and increase in endurance performance (ID 318, 2887) and increase in endurance capacity (ID 318, 2887) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2263, 10.2903/j.efsa.2011.2263 · DOI
  21. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to sodium and maintenance of normal muscle function (ID 359) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2260, 10.2903/j.efsa.2011.2260 · DOI
  22. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to carbohydrate‐electrolyte solutions and reduction in rated perceived exertion/effort during exercise (ID 460, 466, 467, 468), enhancement of water absorption during exercise (ID 314, 315, 316, 317, 319, 322, 325, 332, 408, 465, 473, 1168, 1574, 1593, 1618, 4302, 4309), and maintenance of endurance performance (ID 466, 469) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2211
  23. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to adenosine triphosphate (ATP) and maintenance of normal muscle function (ID 1946) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2081, 10.2903/j.efsa.2011.2081 · doi:10.2903/j.efsa.2011.2081
  24. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to caffeine and increase in physical performance during short‐term high‐intensity exercise (ID 737, 1486, 1489), increase in endurance performance (ID 737, 1486), increase in endurance capacity (ID 1488) and reduction in the rated perceived exertion/effort during exercise (ID 1488, 1490) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2053
  25. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to creatine and increase in physical performance during short‐term, high intensity, repeated exercise bouts (ID 739, 1520, 1521, 1522, 1523, 1525, 1526, 1531, 1532, 1533, 1534, 1922, 1923, 1924), increase in endurance capacity (ID 1527, 1535), and increase in endurance performance (ID 1521, 1963) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2303
  26. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to bovine colostrum (ID 1472, 1473, 1474, 1475, 1476, 1889, 1890) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2048, 10.2903/j.efsa.2011.2048 · DOI
  27. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to β‐hydroxy β‐methylbutyrate monohydrate (HMB) alone or in combination with α‐ketoisocaproic acid (KIC) and reduction of muscle tissue damage during exercise (ID 1577, 1584), increase in lean body mass (ID 1579, 1582, 1583), increase in muscle strength (ID 1578, 1583, 1587), increase in endurance performance (ID 1580, 1581), skeletal muscle tissue repair (ID 1586) and faster recovery from muscle fatigue after exercise (ID 1576, 1585) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2227
  28. EFSA NDA Panel, 2011, Scientific Opinion on the substantiation of health claims related to casein protein hydrolysates and growth or maintenance of muscle mass (ID 1498), increase in endurance performance (ID 660, 1497) and faster recovery from muscle fatigue after exercise (ID 660, 1497) pursuant to Article 13(1) of Regulation (EC) No 1924/2006, EFSA Journal, 9, 2213, 10.2903/j.efsa.2011.2213 · doi:10.2903/j.efsa.2011.2213
  29. EFSA NDA Panel, 2012, Scientific Opinion on the substantiation of a health claim related to citrulline‐malate and faster recovery from muscle fatigue after exercise pursuant to Article 13(5) of Regulation (EC) No 1924/2006, EFSA Journal, 10, 2699, 10.2903/j.efsa.2012.2699 · DOI
  30. EFSA NDA Panel, 2012, Guidance on the scientific requirements for health claims related to physical performance, EFSA Journal, 10, 2817
  31. EFSA NDA Panel, 2012, Guidance on the scientific requirements for health claims related to appetite ratings, weight management, and blood glucose concentrations, EFSA Journal, 10, 2604
  32. EFSA NDA Panel, 2013, Scientific Opinion on the substantiation of a health claim related to glycaemic carbohydrates and recovery of normal muscle function (contraction) after strenuous exercise pursuant to Article 13(5) of Regulation (EC) No 1924/2006, EFSA Journal, 11, 3409
  33. EFSA NDA Panel, 2014, Scientific Opinion on the substantiation of a health claim related to citrulline‐malate and faster recovery from muscle fatigue after exercise pursuant to Article 13(5) of Regulation (EC) No 1924/2006, EFSA Journal, 12, 3650
  34. EFSA NDA Panel, 2014, Scientific Opinion on the substantiation of a health claim related to beta‐alanine and increase in physical performance during short‐duration, high‐intensity exercise pursuant to Article 13(5) of Regulation (EC) No 1924/2006, EFSA Journal, 12, 3755, 10.2903/j.efsa.2014.3755 · DOI
  35. EFSA NDA Panel, 2014, Scientific Opinion on the substantiation of a health claim related to carbohydrate solutions and maintenance of physical performance during endurance exercise pursuant to Article 13(5) of Regulation (EC) No 1924/2006, EFSA Journal, 12, 3836, 10.2903/j.efsa.2014.3836 · DOI
  36. EFSA NDA Panel, 2016, General scientific guidance for stakeholders on health claim applications, EFSA Journal, 14, 4367
  37. EFSA NDA Panel, 2016, Scientific opinion on creatine in combination with resistance training and improvement in muscle strength: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, EFSA Journal, 14, 4400
  38. Turck, 2017, Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 2), EFSA Journal, 15, 4680
  39. Turck, 2018, Scientific Opinion on the carbohydrate solutions and contribute to the improvement of physical performance during a high‐intensity and long‐lasting physical exercise: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, EFSA Journal, 16, 5191
  40. Fisher, 2012, Attempting to better define “intensity” for muscular performance: is it all wasted effort?, European Journal of Applied Physiology, 112, 4183, 10.1007/s00421-012-2463-0 · DOI
  41. Howley, 2001, Type of activity: resistance, aerobic and leisure versus occupational physical activity, Medicine and Science in Sports and Exercise, 33, S364, 10.1097/00005768-200106001-00005 · DOI · Paper page
  42. Winter, 2016, Misuse of “Power” and Other Mechanical Terms in Sport and Exercise Science Research, Journal of Strength and Conditioning Research, 30, 292, 10.1519/JSC.0000000000001101 · DOI · Paper page

Cited by

Metadata

Authors
EFSA Panel on Nutrition, N. F. A. F. A. (. N. P., Turck, D., Castenmiller, J., De Henauw, S., Hirsch‐Ernst, K. I., Kearney, J., Knutsen, H. K., Maciuk, A., Mangelsdorf, I., McArdle, H. J., Naska, A., Pelaez, C., Pentieva, K., Thies, F., Tsabouri, S., Vinceti, M., Bresson, J., Burlingame, B., Dean, T., Fairweather‐Tait, S., Heinonen, M., Neuhäuser‐Berthold, M., Nowicka, G., Sanz, Y., Sjödin, A., Stern, M., Tomé, D., Van Loveren, H., Willatts, P., Martin, A., Strain, J. J., Heng, L., Valtueña Martínez, S., & Siani, A.
Venue
EFSA Journal
Publisher
Wiley
Published
2018-10
Volume
16
Issue
10
Pages
e05434-e05434
ISSN
1831-4732 (ISSN-L)
OpenAlex
W2899013637
Cited by
19
References
3
FWCI
3.08
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.